New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers identify factors associated with COVID-19 vaccination acceptance among cancer patients

Researchers identify factors associated with COVID-19 vaccination acceptance among cancer patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainCancer patients are at higher risk of poor outcomes from COVID-19 infection due to their disease and ther
Oncology February 03,2024
Researchers identify factors associated with COVID-19 vaccination acceptance among cancer patients

Researchers identify factors associated with COVID-19 vaccination acceptance among cancer patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainCancer patients are at higher risk of poor outcomes from COVID-19 infection due to their disease and ther
Oncology February 03,2024
Study: Vaccine helps drug keep melanoma patients cancer-free

Study: Vaccine helps drug keep melanoma patients cancer-free

by Angelica PeeblesCredit: Unsplash/CC0 Public DomainAdding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-de
Oncology February 03,2024
Study: Vaccine helps drug keep melanoma patients cancer-free

Study: Vaccine helps drug keep melanoma patients cancer-free

by Angelica PeeblesCredit: Unsplash/CC0 Public DomainAdding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-de
Oncology February 03,2024
Researchers develop alcohol intervention for women attending breast screening appointments

Researchers develop alcohol intervention for women attending breast screening appointments

by Monash UniversityCredit: Unsplash/CC0 Public DomainMonash University, Turning Point and the Victorian Health Promotion Foundation (VicHealth) have developed a successful alcohol intervention f
Oncology February 03,2024
Researchers develop alcohol intervention for women attending breast screening appointments

Researchers develop alcohol intervention for women attending breast screening appointments

by Monash UniversityCredit: Unsplash/CC0 Public DomainMonash University, Turning Point and the Victorian Health Promotion Foundation (VicHealth) have developed a successful alcohol intervention f
Oncology February 03,2024
Key human bladder cancer genes pinpointed in cats and dogs

Key human bladder cancer genes pinpointed in cats and dogs

by Wellcome Trust Sanger InstituteCredit: Unsplash/CC0 Public DomainKey bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding
Oncology February 03,2024
Key human bladder cancer genes pinpointed in cats and dogs

Key human bladder cancer genes pinpointed in cats and dogs

by Wellcome Trust Sanger InstituteCredit: Unsplash/CC0 Public DomainKey bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding
Oncology February 03,2024
Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

by Arthur AllenCredit: CC0 Public DomainOn Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredd
Oncology February 03,2024
Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

by Arthur AllenCredit: CC0 Public DomainOn Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredd
Oncology February 03,2024
Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise
Oncology February 03,2024
Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise
Oncology February 03,2024
Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283
Oncology February 03,2024
Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283
Oncology February 03,2024
Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h
Oncology February 03,2024
Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h
Oncology February 03,2024
Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for
Oncology February 03,2024
Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for
Oncology February 03,2024
A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and
Oncology February 03,2024
A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and
Oncology February 03,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com